Brazil plans to expand a crackdown on companies that patent products made from rare plants and animals without adequately compensating the South American country or its indigenous communities.
The fight against “biopiracy” has won the support of indigenous communities and defenders of the Amazon rain forest who say corporations unfairly benefit from medicine and other products derived from Brazil’s exotic plants, poisonous snakes or brightly colored frogs.
However, the effort has sparked criticism that it slows crucial scientific research and arbitrarily targets entrepreneurs that could develop environmentally sustainable businesses.
Brazil has levied more than 100 million reais (US$59 million) in fines since July on companies charged with not paying fair compensation for the use of genetic material native to Brazil, said Bruno Barbosa, who heads inspection for the environmental oversight agency Ibama.
Next year, officials will begin pursuing companies that did not notify the government of their use of local species to create products such as pharmaceuticals, as required by law, meaning fines will likely go up.
“Given that [fighting biopiracy] is a new process and that Brazil has one of the biggest reserves of biodiversity in the world, I think most of this activity is illegal, and we’re going to find those people,” he said.
Barbosa says examples of biopiracy abound, such as the development in the 1970s of the hypertension medication captopril from a snake venom that indigenous groups used on arrowhead tips.
Pharmaceuticals companies also used the yellow-and-green Kambo frog, found in Brazil’s Amazon state of Acre, to create anti-inflammatory drugs without distributing benefits to local residents, he said. Many of these incidents came before a 2001 decree that created the current rules governing species use.
The government this year stepped up the anti-biopiracy effort with a campaign known as “Operation New Direction” that aims to crack down on what it calls profiteering.
Fines next year may rise to US$29 million each and companies face possible cancelation of patents in Brazil if inspectors find they did not register the use of local species.
One of the biggest fines levied so far was on Brazil’s largest cosmetics maker Natura, Barbosa said. He declined to give details on the amount or the infraction because the process is ongoing.
Critics say Brazil’s often aggressive efforts to prevent biopiracy threaten to slow crucial scientific research that could provide new cancer treatments or remedies for diseases suffered by local populations.
They said it treats anyone interested in commercial use of rare species as possibly criminal, complicating government goals of developing research facilities near where the species are found to create jobs in those communities.
The government should make the rules clearer because the current system ends up penalizing those that make the most effort to be transparent about their use of genetic material, said Raul Telles do Valle who works with ISA, a think tank on social and environmental issues.
“The current law is very vague on a lot of points, it ends up classifying everybody as illegitimate,” he said. “Just passing out fines under the existing framework isn’t going to solve the problem.”
The law should reflect the difficulty of determining how to compensate local populations from collective knowledge passed down over generations, he said.
Barbosa says the government’s legislation is suitable and that expanding the fight against biopiracy could reduce the destruction of sensitive environments.
“This is going to enable concrete alternatives that substitute destruction of the ecosystem for new economic mechanisms,” he said.
HORMUZ ISSUE: The US president said he expected crude prices to drop at the end of the war, which he called a ‘minor excursion’ that could continue ‘for a little while’ The United Arab Emirates (UAE) and Kuwait started reducing oil production, as the near-closure of the crucial Strait of Hormuz ripples through energy markets and affects global supply. Abu Dhabi National Oil Co (ADNOC) is “managing offshore production levels to address storage requirements,” the company said in a statement, without giving details. Kuwait Petroleum Corp said it was lowering production at its oil fields and refineries after “Iranian threats against safe passage of ships through the Strait of Hormuz.” The war in the Middle East has all but closed Hormuz, the narrow waterway linking the Persian Gulf to the open seas,
Apple Inc increased iPhone production in India by about 53 percent last year and now makes a quarter of its marquee devices there, reflecting the US company’s efforts to avoid tariffs on China. The company assembled about 55 million iPhones in India last year, up from 36 million a year earlier, people familiar with the matter said, asking not to be named because the numbers aren’t public. Apple makes about 220 million to 230 million iPhones a year globally, with India’s share of the total increasing rapidly. Apple has accelerated its expansion in the world’s most populous country in recent years, bolstered
HEADWINDS: The company said it expects its computer business, as well as consumer electronics and communications segments to see revenue declines due to seasonality Pegatron Corp (和碩) yesterday said it aims to grow its artificial intelligence (AI) server revenue more than 10-fold this year from last year, driven by orders from neocloud solutions clients and large cloud service providers. The electronics manufacturing service provider said AI server revenue growth would be driven primarily by the Nvidia Corp GB300 server platform. Server shipments are expected to increase each quarter this year, with the second half likely to outperform the first half, it said. The AI server market is expected to broaden this year as more inference applications emerge, which would drive demand for system-on-chip, application-specific integrated circuits
PROJECTION: TSMC said it expects strong growth this year, with revenue in US dollars projected to grow by about 30 percent, outperforming the industry Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday reported consolidated sales last month reached NT$317.66 billion (US$9.98 billion), the highest ever for the month of February, driven by robust demand for chips built using the company’s advanced 3-nanometer (3nm) process. Last month’s figure was up 22.2 percent from a year earlier, but fell 20.8 percent from January, the world’s largest contract chipmaker said in a statement. For the first two months of the year, TSMC posted cumulative sales of NT$718.91 billion, up 29.9 percent from a year earlier. Analysts attributed the growth to sustained global demand for artificial intelligence (AI) products